Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any retinitis pigmentosa in which the cause of the disease is a mutation in the ZNF408 gene.
Features include always present findings: Constriction of peripheral visual field, Bone spicule pigmentation of the retina, Nyctalopia, and Reduced visual acuity and others; and common findings: High myopia, Peripapillary atrophy, and Photophobia.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 3 | Optic disc pallor, Posterior subcapsular cataract, Attenuation of retinal blood vessels |
ZNF408 function has not been fully characterized.
Retinitis pigmentosa 72 is associated with mutations in the ZNF408 gene on chromosome 11.
Genetic testing for ZNF408 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for retinitis pigmentosa 72 has been reported in the published literature.
Phenotype severity distribution: 8 always present features, 3 common features.
No clinical trials have been registered for retinitis pigmentosa 72.
43 publications have been identified in PubMed for retinitis pigmentosa 72. Research spans Epidemiology / Natural History (33%), Basic Science / Preclinical (21%), and Review / Meta-Analysis (14%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 14 | 33% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 11:55 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Bones and joints |
1 |
Bone spicule pigmentation of the retina |
Muscles | 1 | Peripapillary atrophy |
Laboratory research
9 |
21% |
Research summaries | 6 | 14% |
Patient case studies | 5 | 12% |
Clinical study results | 4 | 9% |
New treatment approaches | 3 | 7% |
Other research | 1 | 2% |
Testing and diagnosis research | 1 | 2% |
Liu Y (2026). [PMID: 41448483](https://pubmed.ncbi.nlm.nih.gov/41448483/). *American journal of ophthalmology*. [Epidemiology / Natural History]
Reuter P (2026). [PMID: 42192302](https://pubmed.ncbi.nlm.nih.gov/42192302/). *Mol Med*. [Review / Meta-Analysis]
Shin JH (2026). [PMID: 42150619](https://pubmed.ncbi.nlm.nih.gov/42150619/). *Can J Ophthalmol*. [Basic Science / Preclinical]
Hong SY (2026). [PMID: 42415635](https://pubmed.ncbi.nlm.nih.gov/42415635/). *Korean J Ophthalmol*. [Clinical Trial Publication]
Sung JY (2026). [PMID: 41341794](https://pubmed.ncbi.nlm.nih.gov/41341794/). *Ophthalmol Sci*. [Epidemiology / Natural History]
Karuntu JS (2026). [PMID: 42433200](https://pubmed.ncbi.nlm.nih.gov/42433200/). *Clin Exp Ophthalmol*. [Epidemiology / Natural History]
Denee T (2026). [PMID: 41964899](https://pubmed.ncbi.nlm.nih.gov/41964899/). *Curr Med Res Opin*. [Epidemiology / Natural History]
Romo-Aguas JC (2026). [PMID: 42022048](https://pubmed.ncbi.nlm.nih.gov/42022048/). *Ophthalmol Sci*. [Epidemiology / Natural History]
Christou EE (2026). [PMID: 42694306](https://pubmed.ncbi.nlm.nih.gov/42694306/). *Ther Adv Ophthalmol*. [Review / Meta-Analysis]
Theunis M (2026). [PMID: 41126390](https://pubmed.ncbi.nlm.nih.gov/41126390/). *Ophthalmic Genet*. [Review / Meta-Analysis]